7 results
10-K
2021 FY
FNA
Paragon 28 Inc
8 Mar 22
Annual report
4:14pm
, medical society recommendations and other analyses, that our products provide a safe and effective treatment for foot and ankle conditions. Even if we
424B4
FNA
Paragon 28 Inc
18 Oct 21
Prospectus supplement with pricing info
4:34pm
to adopt our products. Physicians may not adopt our products unless they are able to determine, based on experience, clinical data, medical society
S-1/A
FNA
Paragon 28 Inc
29 Sep 21
IPO registration (amended)
5:17pm
not adopt our products unless they are able to determine, based on experience, clinical data, medical society recommendations and other analyses, that our
S-1
q80rwlp
24 Sep 21
IPO registration
5:07pm
DRS/A
sosaxbj82i7uzqf73q
9 Sep 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next